Role of Low-Molecular-Weight Heparin in Unexplained Recurrent Pregnancy Loss
Status:
COMPLETED
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
Using low-molecular-weight heparin (LMWH), outcomes such as live birth rate and the occurrence of pregnancy complications are some of the variables reported in some studies, with varying degrees of success. The present study aimed to compare the role of LMWH in unexplained recurrent pregnancy loss.